Myricetin alleviates the formaldehyde-enhanced Warburg effect in tumor cells through inhibition of HIF-1α
Authors:
- 15 September 2022
- journal article
- research article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 454, 116246
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Myricetin: A Dietary Molecule with Diverse Biological ActivitiesNutrients, 2016
- HIF-1α pathway: role, regulation and intervention for cancer therapyActa Pharmaceutica Sinica B, 2015
- Reciprocal Regulation of HIF-1α and LincRNA-p21 Modulates the Warburg EffectMolecular Cell, 2014
- Pilot trial of EZN-2968, an antisense oligonucleotide inhibitor of hypoxia-inducible factor-1 alpha (HIF-1α), in patients with refractory solid tumorsCancer Chemotherapy and Pharmacology, 2013
- Recent agents targeting HIF‐1α for cancer therapyJournal of Cellular Biochemistry, 2013
- A novel approach to cancer therapy using PX-478 as a HIF-1α inhibitorArchives of Pharmacal Research, 2011
- Determination of trace formaldehyde in blood plasma by resonance fluorescence technologyAnalytica Chimica Acta, 2011
- Neuroprotection of deferoxamine on rotenone-induced injury via accumulation of HIF-1α and induction of autophagy in SH-SY5Y cellsNeurochemistry International, 2010
- CoCl2, a Chemical Inducer of Hypoxia‐Inducible Factor‐1, and Hypoxia Reduce Apoptotic Cell Death in Hepatoma Cell Line HepG2Annals of the New York Academy of Sciences, 2002
- Structural basis for Hif-1α/CBP recognition in the cellular hypoxic responseProceedings of the National Academy of Sciences, 2002